JAM3 Gene Hemorrhagic Destruction of the Brain Subependymal Calcification and Cataracts Genetic Test
Are you or your loved ones experiencing symptoms such as brain destruction, subependymal calcification, and cataracts? If so, the JAM3 Gene Hemorrhagic Destruction of the Brain Subependymal Calcification and Cataracts Genetic Test may provide valuable insights.
Test Details
The JAM3 gene is associated with a rare genetic disorder known as Hemorrhagic Destruction of the Brain, Subependymal Calcification, and Cataracts (HDBSC). This disorder is characterized by the progressive destruction of brain tissue, the presence of calcium deposits in the lining of the brain’s ventricles (subependymal calcification), and the development of cataracts in the eyes.
NGS (Next-Generation Sequencing) genetic testing is a cutting-edge technique that allows for the analysis of multiple genes simultaneously. This enables the detection of genetic variations or mutations that may be responsible for a particular disorder. In the case of HDBSC, NGS genetic testing can identify mutations in the JAM3 gene, which is associated with this disorder.
By analyzing an individual’s DNA sample, NGS genetic testing can provide valuable information about the presence of mutations in the JAM3 gene. This information can help confirm a diagnosis of HDBSC, especially in cases where symptoms are atypical or other diagnostic methods have been inconclusive.
Test Components and Price
The JAM3 Gene Hemorrhagic Destruction of the Brain Subependymal Calcification and Cataracts Genetic Test is available for a cost of AED 4400.0. The test can be conducted using blood or extracted DNA, or even a single drop of blood on an FTA card.
Report Delivery and Method
After the test is conducted, the report will be delivered within 3 to 4 weeks. The test utilizes NGS technology, which ensures accurate and efficient analysis of the JAM3 gene.
Test Type and Doctor
The JAM3 Gene Hemorrhagic Destruction of the Brain Subependymal Calcification and Cataracts Genetic Test falls under the category of Vascular Diseases. It is recommended to consult a General Physician for this test.
Test Department and Pre-Test Information
The JAM3 Gene Hemorrhagic Destruction of the Brain Subependymal Calcification and Cataracts Genetic Test is conducted by the Genetics department. Before undergoing the test, it is essential to provide the clinical history of the patient. Additionally, a Genetic Counselling session may be conducted to create a pedigree chart of family members affected by the disorder.
Importance of Genetic Testing
It is crucial to note that genetic testing should be performed by a qualified healthcare professional who can provide appropriate counseling and support before and after the test. The results of genetic testing can have significant implications for individuals and their families. Therefore, it is essential to have a clear understanding of the potential risks, benefits, and limitations of testing.
If you or your loved ones are experiencing symptoms related to Hemorrhagic Destruction of the Brain, Subependymal Calcification, and Cataracts, consider the JAM3 Gene Hemorrhagic Destruction of the Brain Subependymal Calcification and Cataracts Genetic Test. It may provide the answers you need for a proper diagnosis and treatment plan.
| Test Name | JAM3 Gene Hemorrhagic destruction of the brain subependymal calcification and cataracts Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Vascular Diseases |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for JAM3 Gene Hemorrhagic destruction of the brain, subependymal calcification, and cataracts NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with JAM3 Gene Hemorrhagic destruction of the brain, subependymal calcification, and cataracts NGS Genetic DNA Test gene JAM3 |
| Test Details | The JAM3 gene is associated with a rare genetic disorder called Hemorrhagic Destruction of the Brain, Subependymal Calcification, and Cataracts (HDBSC). This disorder is characterized by the progressive destruction of brain tissue, the presence of calcium deposits in the lining of the brain’s ventricles (subependymal calcification), and the development of cataracts in the eyes. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously, allowing for the detection of genetic variations or mutations that may be responsible for a particular disorder. In the case of HDBSC, NGS genetic testing can be used to identify mutations in the JAM3 gene, which is known to be associated with this disorder. By analyzing an individual’s DNA sample, NGS genetic testing can provide information about the presence of mutations in the JAM3 gene, helping to confirm a diagnosis of HDBSC. This can be particularly useful in cases where the symptoms are atypical or when other diagnostic methods have been inconclusive. It’s important to note that genetic testing should be performed by a qualified healthcare professional who can provide appropriate counseling and support both before and after the test. Genetic testing results can have significant implications for individuals and their families, so it’s crucial to have a clear understanding of the potential risks, benefits, and limitations of testing. |
